Concepedia

Andreas Gollner

AG

20

Publications

1.3K

Citations

15

H-Index

2009

Active since

Affiliations

Boehringer Ingelheim (Austria)(Current)

Boehringer Ingelheim (United States)

Boehringer Ingelheim (Germany)

Vanderbilt University

University of Vienna

Andreas Gollner is an author at Boehringer Ingelheim (Austria) specializing in medicine, pharmacology, and drug discovery.

ORCID

Top concepts

Publications per year

2009–2024

20

Publications

20

Drugging an undruggable pocket on KRAS

Dirk Kessler, Michael Gmachl, Andreas Mantoulidis et al. · Proceedings of the National Academy of Sciences · 2019 · 415 citations · Full text

Regioselective reactions for programmable resveratrol oligomer synthesis

Scott A. Snyder, Andreas Gollner, Maria Chiriac · Nature · 2011 · 203 citations · Full text

, , +4

Targeting cancer with small-molecule pan-KRAS degraders

Johannes Popow, William Farnaby, Andreas Gollner et al. · Science · 2024 · 130 citations · Full text

, , +15

Discovery of Novel Spiro[3<i>H</i>-indole-3,2′-pyrrolidin]-2(1<i>H</i>)-one Compounds as Chemically Stable and Orally Active Inhibitors of the MDM2–p53 Interaction

Andreas Gollner, Dorothea Rudolph, Heribert Arnhof et al. · Journal of Medicinal Chemistry · 2016 · 119 citations

Fragment Optimization of Reversible Binding to the Switch II Pocket on KRAS Leads to a Potent, In Vivo Active KRAS <sup>G12C</sup> Inhibitor

Joachim Bröker, Alex G. Waterson, Chris A. Smethurst et al. · Journal of Medicinal Chemistry · 2022 · 72 citations · Full text

Rows per page

1–5 of 20